US Broker Ratings

Humana Inc. (HUM) Stock Analysis: Navigating Healthcare Plans with 8.50% Upside Potential

For investors eyeing the healthcare sector, Humana Inc. (NYSE: HUM) stands out as a formidable player in the healthcare plans industry. With a market capitalization of $46.38 billion, Humana offers..

Becton, Dickinson and Company (BDX) Stock Analysis: Balancing Dividend Yield and Growth Potential

Becton, Dickinson and Company (NYSE: BDX) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a formidable market capitalization of $49.29..

IDEXX Laboratories, Inc. (IDXX)

⚠️ No article content returned.

..

Pfizer, Inc. (PFE) Stock Analysis: Exploring a 6.22% Dividend Yield Amidst Healthcare Sector Shifts

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to capture investor interest with its robust 6.22% dividend yield, positioning itself as a potentially rewarding option for income-focused..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Navigating the Market with Strong Buy Ratings and Robust Revenue Growth

As a leading player in the healthcare sector, Thermo Fisher Scientific Inc. (NYSE: TMO) stands at the forefront of the diagnostics and research industry. With a formidable market capitalization of..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 17.6% Potential Upside and Strong Revenue Growth

With a rich history dating back to its founding in 1781, Takeda Pharmaceutical Company Limited (NYSE: TAK) stands as a global powerhouse in the healthcare sector, specifically within the specialty..

Sanofi (SNY) Stock Analysis: Exploring a 26.46% Upside Potential in the Healthcare Sector

Sanofi (NASDAQ: SNY), a titan in the healthcare sector, has caught the attention of investors with its substantial market cap of $101.79 billion and a compelling potential upside of 26.46%,..

Investor Outlook: Edwards Lifesciences (EW) Sees 14.39% Upside with Strong Buy Ratings

Edwards Lifesciences Corporation (NYSE: EW), a leader in the medical devices sector with a market capitalization of $50.82 billion, is making waves in the healthcare industry. Known for its innovative..

argenx SE (ARGX) Stock Analysis: Exploring a Promising 19.21% Potential Upside

Investors seeking exposure to the biotech sector might find argenx SE (ARGX) an intriguing opportunity. Based in the Netherlands, this commercial-stage biopharma company is making significant strides in the treatment..

Elevance Health, Inc. (ELV) Stock Analysis: Insights into a Healthcare Giant with Nearly 10% Upside Potential

Elevance Health, Inc. (NYSE: ELV) stands as a formidable player in the healthcare plans industry, boasting a market capitalization of $89.12 billion. As a health benefits company operating in the..

Danaher Corporation (DHR) Stock Analysis: A Healthcare Giant with an 8% Upside Potential

Danaher Corporation (NYSE: DHR), a formidable player in the healthcare sector specializing in diagnostics and research, stands out with its robust market capitalization of $148.9 billion. With its current stock..

Gilead Sciences, Inc. (GILD) Stock Analysis: Exploring Revenue Growth and Strategic Collaborations

Gilead Sciences, Inc. (NASDAQ: GILD) has long been a titan in the healthcare sector, specifically within the drug manufacturing industry. Headquartered in Foster City, California, Gilead has carved out a..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 34% Potential Upside for Investors

Zoetis Inc. (NYSE: ZTS), a leading player in the healthcare sector, specifically within the drug manufacturers – specialty & generic industry, stands as a compelling consideration for investors seeking growth..

CVS Health Corporation (CVS) Stock Analysis: Unlocking a 30.89% Upside Potential in Healthcare

As CVS Health Corporation (NYSE: CVS) continues to solidify its presence in the healthcare sector, individual investors are presented with an interesting opportunity to explore a potential upside of 30.89%...

Amgen Inc. (AMGN) Stock Analysis: Navigating Growth with a Robust Pipeline and a 2.61% Dividend Yield

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to capture the attention of investors with its robust portfolio of therapeutics and promising financial metrics. Headquartered in Thousand..

Abbott Laboratories (ABT) Stock Analysis: Robust Growth and a 17% Upside Potential Beckon Investors

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor interest with its impressive market cap of $178.73 billion and a robust array of healthcare products..

Novartis AG (NVS) Investor Outlook: Evaluating the 11.53% Potential Upside and Robust Dividend Yield

Novartis AG (NYSE: NVS), a powerhouse in the healthcare sector, operates within the global pharmaceutical landscape. With its market capitalization standing at an impressive $266.8 billion, Novartis continues to be..

Boston Scientific Corporation (BSX) Stock Analysis: Unveiling a 42.5% Upside Potential for Investors

Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector specializing in medical devices, offers a compelling investment case with a significant upside potential of 42.5%. As the..

Johnson & Johnson (JNJ) Stock Analysis: Navigating through Healthcare with a Robust Growth and Dividend Outlook

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture investor attention with its expansive market cap of $650.65 billion. As a major player in the..

MBX Biosciences, Inc. (MBX)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds